Inaccurately Reported Statin Use Affects the Assessing of Lipid Profile Measures and Their Association with Coronary Artery Disease Risk
Open Access
- 2 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 70 (3) , 528-537
Abstract
Background: Lipid profiling is central for coronary artery disease (CAD) risk assessment. Nonadherence or unreported use of lipid-lowering drugs, particularly statins, can significantly complicate the association between lipid profile measures and CAD clinical outcomes. By combining medication history evaluation with statin analysis in plasma, we determined the effects of inaccurately reported statin use on lipid profile measures and their association with CAD risk. Methods: We compared medication history of statin use with statin concentration measurements, by liquid chromatography–tandem mass spectrometry, in 690 participants undergoing coronary angiography (63 ± 11 years of age). Nominal logistic regression was employed to model CAD diagnosis with statin measurements, phenotypic, and lipid profile characteristics. Results: Medication history of statin use was confirmed by statin assay for 81% of the patients. Surprisingly, statins were detected in 46% of patients without statin use records. Nonreported statin use was disproportionately higher among older participants. Stratifying samples by statin history resulted in underestimated LDL-lipid measures. Apolipoprotein B concentrations had a significant inverse CAD association, which became nonsignificant upon re-stratification using the statin assay data. Conclusions: Our study uncovered prominent discrepancies between medication records and actual statin use measured by mass spectrometry. We showed that inaccurate statin use assessments may lead to overestimation and underestimation of LDL levels in statin user and nonuser categories, exaggerating the reverse epidemiology association between LDL levels and CAD diagnosis. Combining medication history and quantitative statin assay data can significantly improve the design, analysis, and interpretation of clinical and epidemiological studies.Keywords
This publication has 37 references indexed in Scilit:
- Ten-Year Evolution of Statin Eligibility and Use in a Population-Based CohortThe American Journal of Cardiology, 2022
- Electronic adherence monitoring devices for children with asthma: A systematic review and meta-analysis of randomised controlled trialsInternational Journal of Nursing Studies, 2021
- Lipid paradox in patients with acute myocardial infarction: Potential impact of malnutritionClinical Nutrition, 2019
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive SummaryJACC, 2019
- Simultaneous Quantification of Free Cholesterol, Cholesteryl Esters, and Triglycerides without Ester Hydrolysis by UHPLC Separation and In-Source Collision Induced Dissociation Coupled MS/MSJournal of the American Society for Mass Spectrometry, 2017
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic InterventionsJAMA, 2016
- A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN ExperienceJournal of Cardiovascular Translational Research, 2015
- Relationship Between Serum Low-Density Lipoprotein Cholesterol and In-hospital Mortality Following Acute Myocardial Infarction (The Lipid Paradox)The American Journal of Cardiology, 2015
- Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein CholesterolJAMA, 2006
- Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary SyndromesJAMA, 2002